Unbedside Manners

Ivermectin is a genuinely remarkable pharmaceutical. It has saved millions of lives, earned its discoverers a Nobel Prize, and occupies a critical place on the World Health Organization’s List of Essential Medicines. It is also, perhaps more than any other drug in recent memory, a case study in how scientific credibility can be weaponized, distorted, and ultimately corroded by motivated reasoning and online misinformation.

What Ivermectin Actually Is

Ivermectin is a macrocyclic lactone antiparasitic agent derived from Streptomyces avermitilis, a soil-dwelling bacterium discovered in Japan in the 1970s. Researchers William Campbell and Satoshi Ōmura identified the compound’s antiparasitic potential; their work earned the 2015 Nobel Prize in Physiology or Medicine. The drug was initially developed for veterinary use, then adapted for human medicine in the 1980s.

Chemically, ivermectin is a mixture of two avermectin derivatives (B1a and B1b), large macrolide molecules with a molecular weight of approximately 875 daltons. It works by binding to glutamate-gated chloride ion channels found in invertebrate nerve and muscle cells, causing paralysis and death in parasites. Critically, mammals lack these specific channels in their central nervous systems (the blood-brain barrier provides additional protection), which is why the drug has a favorable safety profile in humans at appropriate doses.

Its approved human indications include onchocerciasis (river blindness), strongyloidiasis, lymphatic filariasis, scabies, and several other parasitic infections. In tropical medicine, it has been transformative.  Mass drug administration programs have dramatically reduced the burden of river blindness across sub-Saharan Africa. In these contexts, it is inexpensive and widely available, typically costing less than a dollar per dose in global health programs. In the United States, generic tablets are available by prescription for roughly $30–$60 for a standard course.

How the Misinformation Started

The COVID-19 pandemic created a desperate market for hope, and ivermectin filled it. In mid-2020, a preprint (not yet peer-reviewed) study from Monash University in Australia reported that ivermectin inhibited SARS-CoV-2 replication in vitro in cell cultures in a lab dish. This finding, unremarkable to researchers familiar with the gap between cell culture results and clinical outcomes, was seized upon by a loose network of physicians, social media personalities, and ideologically motivated commentators who presented it as a suppressed cure.

The Frontline COVID-19 Critical Care Alliance (FLCCC) became perhaps the most prominent institutional voice promoting ivermectin, publishing protocols recommending its use despite the absence of robust clinical trial data. Their claims found amplification on platforms like Twitter, YouTube, and podcast ecosystems already primed for anti-establishment health narratives. The framing was consistent: a cheap, generic drug was being suppressed by regulators and pharmaceutical companies to protect vaccine profits. This narrative required no evidence — it was self-sealing, treating absence of official endorsement as confirmation of conspiracy.

What the Data Actually Shows

Large, well-designed randomized controlled trials have since delivered a clear verdict. The TOGETHER trial (Brazil, 2022), one of the largest and most rigorous, found no benefit of ivermectin versus placebo in reducing hospitalization or extended emergency care among high-risk COVID-19 patients. The Oxford-led PRINCIPLE trial and meta-analyses published in peer-reviewed journals reached similar conclusions. A significant number of the studies that had suggested benefit were found to be flawed or fraudulent, most notably a widely cited paper by researcher Ahmed Elgazzar was retracted after investigators found manipulated data. The Cochrane Collaboration, the gold standard for systematic reviews, concluded that ivermectin has no meaningful impact on COVID-19 outcomes.

Claims about ivermectin as a cancer treatment are even more speculative. Some laboratory studies have shown that ivermectin can disrupt certain cellular signaling pathways at very high concentrations in vitro, but no credible clinical trial data supports its use in human cancer treatment. These findings are early-stage biology at best, and the concentrations required in cell studies exceed what is safely achievable in human blood.

Real Harm From a Real Drug

Ivermectin is not harmless in the wrong context. When it is misused, particularly in the veterinary formulations intended for horses and livestock, which contain far higher doses and different excipient chemicals, significant toxicity can result. During the pandemic, Poison Control Centers across the United States reported sharp spikes in ivermectin-related calls. The FDA documented hospitalizations from self-treatment with veterinary products. Patients reported neurological symptoms, severe gastrointestinal distress, and cardiovascular complications. People delayed or refused proven COVID-19 treatments in favor of an intervention that did not work, and some paid for that decision with their lives.

Legislative Responses

Despite the clinical evidence, several U.S. states have moved to expand ivermectin access. Tennessee (2022) and Arkansas passed legislation allowing pharmacists to dispense ivermectin under standing orders without an individual physician’s prescription. Similar measures have been introduced or passed in Louisiana, New Hampshire, and elsewhere. Proponents frame these bills as expanding medical freedom; critics — including the American Medical Association and most major medical societies — argue they undermine evidence-based prescribing standards and create pathways for people to obtain medication for indications it has not been proven to treat.

The Broader Lesson

Ivermectin’s story is not really about one drug. It is about the machinery of medical misinformation: how legitimate early-stage science gets laundered into clinical claims; how distrust in institutions creates fertile ground for alternative authorities; and how a drug with a real, honored, life-saving history can be hijacked and used as a political and ideological symbol. The parasitologists and tropical medicine specialists who have spent careers deploying ivermectin against river blindness and elephantiasis have watched this unfold with undisguised frustration.

The drug works exactly as well as the evidence says it does, remarkably well against the parasites it was designed to fight, and not at all against the conditions for which it was falsely promoted. That is not suppression. That is science.